Xspray Pharma AB (publ) (OM: XSPRAY)
Health Care · Biotechnology · SE
Skr10.44
-0.19% today · -76.4% 1Y
Xspray Pharma AB (publ) (OM: XSPRAY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $52.38M and employs 24 people.
Over the last twelve months the share price has lost 76.4%, trading between 10.20 and 64.10.
Tweenvest scores Xspray Pharma AB (publ) across four factors: quality 36/100, value 29/100. Its strongest factor is quality.
XSPRAY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $52.38M
- Revenue (TTM)
- $254.44K
- P/E
- —
- EPS
- -3.82
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- Skr64.10
- 52-week low
- Skr10.20
- Avg volume (3M)
- —
- Shares outstanding
- 47.42M
- Employees
- 24
- Next earnings
- —
About Xspray Pharma AB (publ)
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
- ISIN
- SE0009973563
- Founded
- 2003
- Listed since
- Sep 28, 2017
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.09 | -0.46% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.